Table 4 Immunosuppressive regimens used for induction and maintenance phase therapy in LN patients at the renal clinic of St. Paul’s Hospital Millennium Medical College, Addis Ababa, Ethiopia from Sep, 2016 to Oct, 2020 (n = 114)
Phase (type of therapy) | Frequency (%) |
|---|---|
Induction | |
Pred only | 6(5.3%) |
Pred + CYC | 67(58.7%) |
Pred + MMF | 34(29.8%) |
Pred + TAC | 3(2.6%) |
Pred + TAC + MMF | 2(1.8%) |
Pred + RTX | 8(7.1%) |
Maintenance | |
Pred + MMF | 76(66.7%) |
Pred + AZA | 14(12.2%) |
Pred + CYC | 32(28.1%) |
Pred + TAC | 1(0.9%) |
Pred + MMF + TAC | 1(0.9%) |
Pred + RTX | 4(3.5%) |